Prevalence and Factors Associate with Metabolic Syndrome in Psoriasis Patients at Ratchaburi Hospital
Keywords:
psoriasis, metabolic syndrome, prevalanceAbstract
Objective: The purpose was to study prevalence and factors associated with metabolic syndrome in psoriasis patients at Ratchaburi Hospital.
Methods: This was a retrospective cross-sectional analytical study. All data were collected from medical records of 246 psoriasis patients who attended the dermatology clinic at Ratchaburi Hospital from October 1, 2022 to May 31, 2024. The statistical analysis included descriptive statistics and analytic statistics. The statistical significance was set at p < .05.
Results: A total of 246 psoriasis patients was included in this study. The prevalence of metabolic syndrome was 48.8% (95% CI 42.4–55.2). Group of the patients with metabolic syndrome had significantly higher age than the group without metabolic syndrome (p < .001); age of onset more than 40 years had significantly more metabolic syndrome than age of onset before 40 years old (p = .001); and moderate to severe psoriasis had significantly more metabolic syndrome than less severity group (p = .043).
Conclusion: This study showed prevalence of metabolic syndrome in psoriasis patients was 48.8%; and patients with an older age, age of onset after 40 years, and moderate to severe disease were factors associated with metabolic syndrome in psoriasis patients.
References
Gelfand JM, Weinstein R, Porter SB, et al. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005;141(12):1537–41. doi: 10.1001/archderm.141.12.1537.
Aekplakorn W, Kessomboon P, Sangthong R, et al. Urban and rural variation in clustering of metabolic syndrome components in the Thai population: results from the fourth National Health Examination Survey 2009. BMC Public Health 2011;11:854. doi: 10.1186/1471-2458-11-854.
Aekplakorn W, Chongsuvivatwong V, Tatsanavivat P, et al. Prevalence of metabolic syndrome defined by the International Diabetes Federation and National Cholesterol Education Program criteria among Thai adults. Asia Pac J Public Health 2011;23(5):792–800. doi: 10.1177/1010539511424482.
Takahashi H, Iizuka H. Psoriasis and metabolic syndrome. J Dermatol 2012;39(3):212–8. doi: 10.1111/j.1346-8138.2011.01408.x.
Takahashi H, Takahashi I, Honma M, et al. Prevalence of metabolic syndrome in Japanese psoriasis patients. J Dermatol Sci 2010;57(2):143–4. doi: 10.1016/j.jdermsci.2009.11.002.
Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol 2013;68(4):654–62. doi: 10.1016/j.jaad.2012.08.015.
Rodríguez-Zúñiga MJM, García-Perdomo HA. Systematic review and meta-analysis of the association between psoriasis and metabolic syndrome. J Am Acad Dermatol 2017;77(4):657–66. doi: 10.1016/j.jaad.2017.04.1133.
Gisondi P, Fostini AC, Fossà I, et al. Psoriasis and the metabolic syndrome. Clin Dermatol 2018;36(1):21–8. doi: 10.1016/j.clindermatol.2017.09.005.
Kokpol C, Aekplakorn W, Rajatanavin N. Prevalence and characteristics of metabolic syndrome in South-East Asian psoriatic patients: a case-control study. J Dermatol 2014;41(10):898–902. doi: 10.1111/1346-8138.12614.
Chularojanamontri L, Wongpraparut C, Silpa-Archa N, et al. Metabolic syndrome and psoriasis severity in South-East Asian patients: An investigation of potential association using current and chronological assessments. J Dermatol 2016;43(12):1424–8. doi: 10.1111/1346-8138.13540.
Mrowietz U, Kragballe K, Reich K, et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 2011;303(1):1–10. doi: 10.1007/s00403-010-1080-1.
Chan WMM, Yew YW, Theng TSC, et al. Prevalence of metabolic syndrome in patients with psoriasis: a cross-sectional study in Singapore. Singapore Med J 2020;61(4):194–9. doi: 10.11622/smedj.2019152.
Lunawat D, Bubna AK, Sankarasubramaniam A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a prospective, observational, descriptive study from a tertiary health-care center in South India. Muller J Med Sci Res 2017;8(1):31–5. doi: 10.4103/0975-9727.199373
Liu L, Cai XC, Sun XY, et al. Global prevalence of metabolic syndrome in patients with psoriasis in the past two decades: current evidence. J Eur Acad Dermatol Venereol 2022;36(11):1969–79. doi: 10.1111/jdv.18296.
Langan SM, Seminara NM, Shin DB, et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol 2012;132(3 Pt 1):556–62. doi: 10.1038/jid.2011.365.
Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007;157(1):68–73. doi: 10.1111/j.1365-2133.2007.07986.x.
Jung SY, Han K, Jung JH, et al. Cumulative exposure to metabolic syndrome affects the risk of psoriasis differently according to age group: a nationwide cohort study in South Korea. Br J Dermatol 2024;190(3):447–9. doi: 10.1093/bjd/ljad441.
วิชัย เอกพลากร. สำรวจสุขภาพประชาชนไทยและจัดตั้งโครงสร้างพื้นฐานเพื่อพัฒนานวัตกรรมด้านสุขภาพ และนโยบาย. กรุงเทพมหานคร: คณะแพทยศาสตร์โรงพยาบาลรามาธิบดี มหาวิทยาลัยมหิดล; 2566: 151–59.
Mirghani H, Altemani A, Alsaedi E, et al. The association of psoriasis, diabetes mellitus, and hypertension: a meta-analysis. Cureus 2023;15(11):e48855. doi: 10.7759/cureus.48855.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ลิขสิทธิ์บทความเป็นของผู้เขียนบทความ แต่หากผลงานของท่านได้รับการพิจารณาตีพิมพ์ลงวารสารแพทย์เขต 4-5 จะคงไว้ซึ่งสิทธิ์ในการตีพิมพ์ครั้งแรกด้วยเหตุที่บทความจะปรากฎในวารสารที่เข้าถึงได้ จึงอนุญาตให้นำบทความในวารสารไปใช้ประโยชน์ได้ในเชิงวิชาการโดยจำเป็นต้องมีการอ้างอิงถึงชื่อวารสารอย่างถูกต้อง แต่ไม่อนุญาตให้นำไปใช้ในเชิงพาณิชย์
